CEUS Liver Webinar 1
We are pleased to announce an EFSUMB Webinar event, sponsored by Bracco. 'CEUS Liver Webinar 1' to be chaired by Prof. Paul Sidhu with the following speakers of approximately 20 -25 min presentations with a Q&A session to close.
Click here to register for this webinar
- This EFSUMB Webinar event is sponsored by Bracco.
- Once registered your information will be shared with Bracco so they can keep you informed of future webinar events you may be interested in. If you do not wish for your information to be shared please contact us.
- The Webinar is run by Sintesi InfoMedica.
- Once registered, Sintesi InfoMedica will email you with the link to join the webinar.
- Each Webinar participant is entitled to an EFSUMB certificate of attendance with 1 CME Credit if the participant joins the webinar for the required minimum period. This time period is monitored by Sintesi InfoMedica.
- Each EFSUMB Webinar Event has a maximum of 500 participants to ensure a good quality of presentation is available for all.
- The webinar event is recorded and all presentations will available on the EFSUMB website after the event takes place.
SPEAKER: Christoph F Dietrich
Bern, Switzerland
The role of CEUS in diagnosis and patient management of primary liver cancer (HCC)
Learning Objectives:
· The patient at risk
· Screening recommendations
· CEUS criteria of malignancy in liver cirrhosis
· How to perform CEUS
· Liver Imaging Reporting and Data System (LI-RADS), CEUS, CECT, CEMRI
· The frequency (and signs) of benign FLL in liver cirrhosis
· Treatment options
SPEAKER: Mikael Sawatzki
St. Gallen, Switzerland
The role of CEUS in diagnosis and patient management of liver metastases
Learning Objectives:
Liver metastases are the most common malignant liver lesions in a non-cirrhotic liver. On abdominal ultrasound, liver metastases may present as hypoechoic, isoechoic or hyperechoic liver lesions, and differentiation from benign lesions (e.g., hyperechoic hemangiomas versus liver metastases) is not always possible. Contrast-enhanced ultrasound (CEUS) has a high diagnostic accuracy in the detection and differentiation of focal liver lesions. CEUS has also been shown to detect liver metastases missed by CT.
Learning objectives of this webinar include:
- CEUS criteria of malignancy
- Examples of CEUS in various types of liver metastases
- Current study results of CEUS for the detection of colorectal liver metastases
- Recommendation of which patient groups may benefit from additional CEUS
SPEAKER: Eddie Leen
London, UK
The role of CEUS for planning, guidance, monitoring and follow-up of focal ablation therapies in liver cancer
Learning Objectives:
1. To learn about new application of ultrasound in guided interventional procedures: liver malignancy biopsy, primary and secondary liver malignancy ablation.
2. To understand consolidated and new indications to ultrasound-guided interventional procedures: PEI, RFA, MWA, IRE.
3. To appreciate the advantages and disadvantages of ultrasound-guided interventional procedures from consolidated to new applications: analysis of data from personal experiences and literature series comparison and discussion.
4. To become familiar with the new techniques of ultrasound guidance and with the new diagnostic and therapeutic indications for ultrasound-guided interventional procedures: CEUS imaging, fusion imaging, elastosonographic imaging for liver malignancy biopsy and treatment, MWA, IRE, combination treatment.